WACKER’S OFFER PRICE IS EUR80 PER SHARE

--------------------------------------------------------------------------------
ots-CorporateNews transmitted by euro adhoc.
The issuer is responsible for the content of this announcement.
--------------------------------------------------------------------------------

München (euro adhoc) - - OFFER SIZE OF APPROXIMATELY EUR1.2 BILLION INCLUDING
GREENSHOE OPTION
- WACKER SHARES MORE THAN 18 TIMES OVERSUBSCRIBED AT OFFER PRICE
- CEO PETER-ALEXANDER WACKER "WE ARE PLEASED WITH THE STRONG INVESTOR
CONFIDENCE"

Munich, April 8, 2006 - The offer price for WACKER’s IPO has been set at EUR80
per share by Wacker Chemie AG together with the other selling shareholders Blue
Elephant Holding GmbH and Morgan Stanley & Co. Inc., and the Global Coordinators
and Joint Bookrunners Morgan Stanley and UBS Investment Bank. At the offer
price, which is at the upper end of the price range of EUR70 to EUR80, WACKER’s
shares were more than 18 times oversubscribed.

"We are very pleased with the success of the roadshow and the high level of
investor confidence. In our opinion, this confirms our corporate strategy which
is targeted at long-term, profitable growth", said CEO Peter-Alexander Wacker.

Based on the offer price and including the number of treasury shares offered by
the company, Wacker Chemie AG’s market capitalization will be EUR3.97 billion
(if the Greenshoe option is exercised in full). The company will receive
proceeds of about EUR428 million from the sale of treasury shares (if the
Greenshoe option is exercised in full). The free float will be at 28.75 percent
if the Greenshoe option is exercised in full. 20 percent of the free float can
then be attributed to retail investors. Start of trading on the Official Market
(Prime Standard) of the Frankfurt Stock Exchange is scheduled for April 10.
Following the placement of treasury shares, total shares outstanding will be
approximately 49.7 million, assuming the Greenshoe option is exercised in full.

Based on the offer price, and including over-allotment, the total offer size is
approximately EUR1.2 billion with a total of 14,993,873 shares (including
over-allotment) being placed. Excluding over-allotment, 4,571,430 shares were
placed from the holdings of Wacker Chemie AG, 6,935,640 from the holdings of
Blue Elephant Holding GmbH and 1,531,080 from the holdings of Morgan Stanley &
Co. Inc. If exercised, the Greenshoe option comprises of up to 1,955,723
additional shares from the holdings of Wacker Chemie AG (max. 776,953 shares)
and the holdings of Blue Elephant Holding GmbH (max. 1,178,770 shares). 80
percent of the total 14,993,873 shares will go to institutional investors and 20
percent to private investors. All shares (except for treasury shares held by the
company) carry full dividend rights as of January 1, 2006.

The shares were alloted to private investors in Germany in compliance with the
"Principles for the Allotment of Share Issues to Private Investors", issued by
the Stock Exchange Commission of Experts at the Federal Ministry of Finance on
June 7, 2000. All underwriting banks were subject to uniform allotment criteria:
Due to strong demand, only every fourth order was considered under a drawing
scheme. By means of a transparent code, shares were alloted to private investors
who had placed successful orders with one of the participating banks. Retail
investors who received an allocation and who ordered up to 50 shares will
receive a maximum of 30 shares. Those who ordered above 50 shares will be fully
allocated for the first 35 shares. In addition, they will receive 25 percent of
their remaining order. The maximum allocation for retail investors will be 500
shares. About 1.1 percent of the offer size (incl. Greenshoe option) went to the
company’s employees and members of the management board and supervisory board
under a preferential allotment scheme. Approximately 50 percent of the entitled
employees subscribed shares under this preferential allotment scheme.

Dr. Alexander Wacker Familiengesellschaft mbH will continue to own a
55.64-percent shareholding, while Blue Elephant Holding GmbH will retain about
10.86 percent if the Greenshoe option is exercised in full. Wacker Chemie AG
will continue to hold 2.47 million treasury shares (equal to about 4.74
percent), assuming full exercise of the Greenshoe option. For these shares, the
company will by law neither be entitled to voting rights nor to dividend rights.
Morgan Stanley & Co. Inc. will no longer be a shareholder in the company. WACKER
and the major shareholders have undertaken to lock up their remaining shares for
a period of six months from the initial listing of the shares.

The company intends to invest the proceeds in growth areas. One focus is
production-capacity expansion at WACKER SILICONES’ site in Zhangjiagang, China.
Other examples are the construction of a new polysilicon facility in Burghausen
(WACKER POLYSILICON) and capacity expansions for 300-mm wafers (Siltronic). The
proceeds received by Blue Elephant Holding GmbH are intended to refinance the
shares acquired from Sanofi-Aventis in Wacker-Chemie GmbH.

This press release does not constitute an offer to sell or the solicitation of
an offer to purchase the shares or other securities of Wacker Chemie AG. The
offer is made exclusively through and on the basis of the prospectus, as
published, and supplement No. 1 thereto. Investors should not make an investment
decision with respect to the shares or any other securities of Wacker Chemie AG
except on the basis of the information contained in the prospectus and
supplement No. 1 thereto. Free copies of this material are available to
investors from Wacker Chemie AG.

This press release is not an offer of securities for sale in the United States
of America. Securities may not be offered or sold in the United States of
America absent registration or an exemption from registration under the U.S.
Securities Act of 1933, as amended. Any public offering of securities to be made
in the United States of America will be made by means of a prospectus that may
be obtained from Wacker Chemie AG and that will contain detailed information
about the company and management, as well as financial statements.
The information contained in this press release is not for publication or
distribution in the United States of America, Canada, Australia or Japan and
does not constitute an offer of securities for sale in the United States of
America, Canada, Australia or Japan.

This press release is directed only at persons outside the U.K. (the "relevant
persons"). Each solicitation of an offer, each offer and each agreement to
subscribe for, to purchase or to otherwise acquire the securities is directed
only at relevant persons and at certain other persons or will be entered into
only with relevant persons or certain other persons. Persons who are not
relevant persons should not act on the basis of or rely on the information
contained therein.

This press release contains forward looking statements for the future based on
assumptions and estimates of WACKER's Executive Board. Although we assume the
expectations in these forward looking statements are realistic, we cannot
guarantee they will prove to be correct. The assumptions may harbor risks and
uncertainties that may cause the actual figures to differ considerably from the
forward looking statements. Factors that may cause such discrepancies include,
among other things, changes in the economic and business environment, variations
in exchange and interest rates, the introduction of competing products, lack of
acceptance for new products or services, and changes in corporate strategy.
WACKER does not plan to update the forward looking statements, nor does it
assume the obligation to do so.

Further inquiry note:
Christof Bachmair
+49 (0)89 6279 1830
[email protected]

end of announcement euro adhoc 08.04.2006 17:07:56
--------------------------------------------------------------------------------

emitter: Wacker Chemie AG
Hanns-Seidel-Platz 4
D-81737 München
phone: +49 (0) 89 6279 01
FAX: +49 (0) 89 6279 1770
mail: [email protected]
WWW: http://www.wacker.com
ISIN: DE000WCH8881
indexes: CDAX
stockmarkets: admission applied: official dealing: Frankfurter Wertpapierbörse
sector: Chemicals
language: English

OTS-ORIGINALTEXT UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | CNE

print